Xcout Intel
Tr1X
Tr1X is a private, clinical-stage biotechnology company focused on developing regulatory T cell-based products for autoimmune and inflammatory diseases. The company aims to advance Tr1-based immunotherapies to address unmet medical needs and is headquartered in San Diego, California.
Subscribe to see Tr1X’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tr1X at a glance
Tr1X is a biotech company headquartered in United States. Xcout tracks 12 named people at Tr1X, including James Adams (Chief Technical Officer). Xcout recorded 8 job postings from Tr1X in the last 90 days.
Tr1X leadership
- James AdamsChief Technical Officer
- Marco LondeiChief Medical Officer
- Janine PowersHead of Translational Medicine
- Bill LisExecutive Chairman
- David de VriesCo-founder, Chief Executive Officer
- Maria Grazia RoncaroloCo-founder, President and Head of R&D
6 more named people on record for Tr1X, with roles, board committees and tenure — see the full roster →
Hiring at Tr1X
Xcout recorded 8 job postings from Tr1X in the last 90 days, from a hiring record Xcout has kept since September 2026.
The weekly hiring trend, the roles and locations behind it — see Tr1X's hiring signals →
Tr1X competitors
A few of Tr1X's closest competitors — see the full list of competitors and alternatives →
TRex Bio, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California. The company focuses on discovering and developing precision therapeutics to treat moderate-to-severe immune-mediated diseases by targeting regulatory T cells.
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for inflammatory and autoimmune diseases. Headquartered in California, the company advances a robust clinical pipeline and operates as a publicly traded enterprise.
Adcentrx Therapeutics is a privately held biotechnology company founded in 2021 that focuses on accelerating advanced medical treatments. Its research headquarters are located in San Diego, California.
Egle Therapeutics SAS is a clinical-stage biotechnology company headquartered in Paris, France, that develops precision medicines designed to modulate regulatory T cells.
First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.
Paulex Bio Inc. is a biotechnology company headquartered in San Diego, California, focused on transformative treatments for type 1 and type 2 diabetes. Its lead approach targets beta cell regeneration through an oral administration.
Get Tr1X's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Tr1X? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tr1X in Xcout Intel
- 12 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access